Feds to Delay Enforcing No Surprises Act’s Price Reporting Rules

Aug. 21, 2021, 1:58 AM

Health plans will have a reprieve from requirements that they publicly disclose prescription drug prices in machine-readable computer files under regulatory guidance issued Friday.

Enforcement of requirements that plan sponsors publish that information is delayed until July 1, 2022, to allow time for the government to issue regulations implementing the No Surprises Act, the Departments of Labor, Health and Human Services, and the Treasury said in a Frequently Asked Questions document.

The No Surprises Act, which takes effect Jan. 1, 2022, is intended to stop doctors and hospitals from billing patients for out-of-network care given in emergencies or when an ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.